Label: BABYO2- silver, zinc liquid
-
Contains inactivated NDC Code(s)
NDC Code(s): 72136-007-01 - Packager: Oxigenesis, Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 17, 2020
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient Purpose
- PURPOSE
- Uses
- Warnings
- KEEP OUT OF REACH OF CHILDREN
- Directions
- Inactive ingredients
- Package Label - Principal Display Panel
-
INGREDIENTS AND APPEARANCE
BABYO2
silver, zinc liquidProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:72136-007 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SILVER (UNII: 3M4G523W1G) (SILVER - UNII:3M4G523W1G) SILVER 48 mg in 240 mL ZINC (UNII: J41CSQ7QDS) (ZINC - UNII:J41CSQ7QDS) ZINC 6 mg in 240 mL HYPOCHLOROUS ACID (UNII: 712K4CDC10) (ZINC - UNII:J41CSQ7QDS) HYPOCHLOROUS ACID 65.8 mg in 240 mL Inactive Ingredients Ingredient Name Strength WATER (UNII: 059QF0KO0R) LAPONITE (UNII: D703131383) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) HYDROCHLORIC ACID (UNII: QTT17582CB) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72136-007-01 240 mL in 1 TUBE; Type 0: Not a Combination Product 09/20/2020 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 09/20/2020 Labeler - Oxigenesis, Inc. (006774725) Establishment Name Address ID/FEI Business Operations Oxigenesis, Inc. 006774725 manufacture(72136-007)